TALOPH(SH:600222) Shang Hai Zheng Quan Bao·2025-09-19 18:59Core Viewpoint - The company, Henan Tailong Pharmaceutical Co., Ltd., is set to enhance its financing efficiency by accepting a guarantee from its indirect controlling shareholder, Zhengzhou High-tech Investment Holding Group Co., Ltd., for loans up to 697 million yuan, with a guarantee fee not exceeding 13.8592 million yuan [2][4][15]. Summary by Sections 1. Overview of Related Transactions - The indirect controlling shareholder, High-tech Investment Holding, will provide a joint liability guarantee for loans up to 697 million yuan, effective until March 30, 2028 [2][4]. - The total estimated guarantee fee is capped at 13.8592 million yuan, calculated as a fixed fee of 1.35 million yuan plus a 0.7% annual rate [4][10]. 2. Related Party Information - High-tech Investment Holding is the indirect controlling shareholder of the company, classified as a related party under the Shanghai Stock Exchange rules [6][8]. - The company maintains independence in personnel, assets, finance, and operations from High-tech Investment Holding [8]. 3. Financial Impact and Approval Process - The transaction is expected to improve the company's financing operations and is deemed necessary for its business development [15]. - The independent directors reviewed and approved the transaction, confirming that the guarantee fee is fair and does not harm the interests of the company or its minority shareholders [15][16].